In This Edition

Key Takeaways

The European Medicines Agency announced AstraZeneca vaccine’s benefits continue to outweigh its risks. The US and Iraq agreed to a full withdrawal of US troops without announcing a timeline. Federal Reserve officials say the dangers of inflation are “broadly balanced.” Analysis: Science Under the Scope: Long-Term Neurological Complications from COVID-19 Infection; Region in Charts: Europe’s Fourth Wave.

Condition Updates

A rundown of important global developments in markets, in business, and region-by-region, as well as statistical risk assessments by country and by US state. [Flashpoint Daily Situation Reports]

Science Under the Scope: Long-Term Neurological Complications from COVID-19 Infection

The world is now 14 months into the COVID-19 pandemic and scientists and public health officials have come a long way in understanding the impact of the virus. Over the last several months an increasing number of studies have been released chronicling the ongoing challenges faced by COVID-19 survivors.

Region in Charts: Europe’s Fourth Wave

Conditions in Europe show signs of stabilizing. While France, Turkey and Poland continue to report very high numbers of daily new infections, the outbreaks in the rest of the region are easing. Europe is no longer the epicenter of the pandemic.

Download the article